Pre-eclampsia. Pre-eclampsia
Conditions
Interventions
Intervention 1: Intervention group 1: Pregnant women in the 12-20 weeks of pregnancy who are at high risk of preeclampsia are treated with aspirin at a dose of 160 mg daily for 36 weeks. Aspirin table
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Pregnant women at 12-20 weeks of gestation at high risk for Preeclampsia.
Exclusion criteria
Exclusion criteria: Patients who find it difficult to follow a regular pattern of medication. Patients with heart, liver, thyroid, peptic ulcer diseases and bleeding disorder. Patients with a history of asthma, aspirin sensitivity, and the presence of major fetal disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Preeclampsia. Timepoint: From 12-20 to 36 weeks of pregnancy. Method of measurement: Mercury sphygmomanometer / laboratory abnormalities (including doubling of liver enzymes, doubling of serum creatinine and drop in platelets below 100,000). | — |
Secondary
| Measure | Time frame |
|---|---|
| Type of delivery (cesarean section or vaginal). Timepoint: Time of delivery. Method of measurement: Based on medical file and disease progression.;Term or preterm delivery. Timepoint: Time of pregnancy termination. Method of measurement: Based on medical file and disease progression. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParia Panahinia
Shahid Beheshti University of Medical Sciences
Outcome results
None listed